TrialSignal
Clinical trial intelligence report
Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04080544-Jul 28, 2026
NCT ID
NCT04080544
Status
COMPLETED
Phase
PHASE2
Sponsor
Neil M Rofsky, MD, MHA
Executive brief
Investment-Ready Snapshot
Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study is a PHASE2 clinical asset sponsored by Neil M Rofsky, MD, MHA in Alzheimer Disease, Cognitive Decline. SEO and diligence focus: [18F]AV-1451, Positron Emission Tomography, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04080544
Indication
Alzheimer Disease
Modality
small molecule
Target
[18F]AV-1451, Positron Emission Tomography
Intervention
[18F]AV-1451, Positron Emission Tomography
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.